Become a Member

Quest Diagnostics Incorporated (DGX)

Healthcare • Medical - Diagnostics & Research

48
Beobachten
$207,80
Price
-0,83%
Change
23,12 Mrd. $
Market Cap
-
P/E Ratio

Neumann-Score Stock Analysis

48
out of 100
Beobachten
Valuation??/100
Profitability??/100
Growth??/100

Unlock Score Details

Become a member and get access to all analyses.

Become a Member

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and o ...

CEO
James E. Davis
Employees
55.000
Country
US